31 results match your criteria: "Ann B. Barshinger Cancer Institute[Affiliation]"
J Palliat Care
January 2020
Pennsylvania State University College of Medicine, Section of Palliative Care, Hershey, PA, USA.
Context: Palliative care in oncology provides multiple benefits, however access to specialty palliative clinicians is limited in community cancer centers. Individual support services are more often available, but little is known on the utilization and impact of these services.
Objectives: To describe the utilization of outpatient support services in the advanced cancer population and the association with ED and hospital use in a community setting.
Purpose: Early integration of outpatient palliative care (OPC) benefits patients with advanced cancer and also the health care systems in which these patients are seen. Successful development and implementation of models of OPC require attention to the needs and values of both the patients being served and the institution providing service.
Summary: In the 2016 clinical guideline, ASCO recommended integrating palliative care early in the disease trajectory alongside cancer-directed treatment.
Expert Opin Drug Saf
July 2016
b Mount Sinai School of Medicine , Tisch Cancer Institute, New York , NY , USA.
Cutis
September 2015
Ann B. Barshinger Cancer Institute, 2102 Harrisburg Pike, Lancaster, PA 17601, USA.
Recognizing current trends and obstacles in melanoma clinical trial development is critical to future progress in this field. This article examines the melanoma research enterprise to identify changing trends and potential barriers to success. All trials registered at ClinicalTrials.
View Article and Find Full Text PDFTrials
August 2015
Icahn School of Medicine, Tisch Cancer Institute, Mount Sinai, NY, USA.
Background: Manuscript abstracts represent a critical source of information for oncology practitioners. Practitioners may utilize the information contained in abstracts as a basis for treatment decisions particularly when full-text articles are not accessible. In 2007, the Consolidated Standards of Reporting Trials (CONSORT) extension statement for abstracts provided a minimum list of elements that should be included in abstracts.
View Article and Find Full Text PDF